Prosecution Insights
Prosecution Insights
248 pending office actions • 135 clients • 214 examiners • 95 art units • 0 of 248 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 114 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 114 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 3 (1%) |
| §101 + other | 28 (11%) |
| §103 only | 61 (25%) |
| §102 only | 6 (2%) |
| §112 only | 37 (15%) |
| Double-patenting only | 2 (1%) |
| Double-patenting + other | 19 (8%) |
| Multi-statute (no §101) | 88 (35%) |
| No statute on record | 4 (2%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JACKSON, SHAWQUIA | 3 | 77.9% | -3.4% |
| WANG, CHANG YU | 3 | 33.4% | +53.3% |
| ANDERSON, REBECCA L | 3 | 73.3% | +23.8% |
| MARTIN, KEVIN STEPHEN | 3 | 75.7% | +24.4% |
| ABBAS, SYED JARAR | 2 | 0.0% | +0.0% |
| DEVEAU ROSEN, JASON | 2 | 80.1% | +16.4% |
| VALENROD, YEVGENY | 2 | 72.6% | +25.1% |
| ZHONG, WAYNESHAOBIN | 2 | 72.5% | +21.3% |
| KUMAR, VINOD | 2 | 82.7% | +20.4% |
| PAGE, BRENT T | 2 | 82.4% | +10.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19131469 | A SPINACH PLANT RESISTANT TO DOWNY MILDEW AND A RESISTANCE GENE | DEVEAU ROSEN, JASON | — |
| 18987408 | HYBRID TOMATO VARIETIES 'E15A43013', 'E15B43148', ‘E15B43155’, AND ‘E15C42988’ | PAGE, BRENT T | — |
| 18654512 | LETTUCE VARIETIES ‘E01C11866’, ‘E01L30616’ AND ‘E01B11959’ | DEVEAU ROSEN, JASON | — |
| 18111251 | Watermelon variety 'RIO GRANDE (E26C.00139)' | PAGE, BRENT T | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18977008 | VACCINES COMPRISING METHANOBREVIBACTER GOTTSCHALKII | FOLEY, SHANON A | 264d overdue |
| 16964965 | ANTIBODY-DRUG CONJUGATES THAT TARGET DLK1 AND USES THEREOF | PUTTLITZ, KARL J | 219d overdue |
| 17554823 | FAP-ACTIVATED RADIOTHERANOSTICS AND USES RELATED THERETO | WESTERBERG, NISSA M | 183d overdue |
| 18011408 | AMIDO COMPOUNDS | JACKSON, SHAWQUIA | 112d overdue |
| 17473362 | METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES USING FNDC5 | MARTINEZ, TARA L | 99d overdue |
| 17723828 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | TRAN, ERIC | 89d overdue |
| 18248922 | SYSTEMS AND METHODS FOR PRODUCTION OF MATERIALS USED IN ADDITIVE MANUFACTURING | GRAHAM, ANDREW D | 87d overdue |
| 18016209 | METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION | REDDIG, PETER J | 73d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18018207 | ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF | MARTIN, KEVIN STEPHEN | 31d overdue |
| 17923456 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | WANG, CHANG YU | 26d overdue |
| 18268102 | METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND STAT3-LINKED CANCERS USING SUPPRESSORS OF ELECTRON LEAK | MARTIN, KEVIN STEPHEN | 6d |
| 17784145 | COMPOSITIONS AND METHODS FOR TREATING NEUROMUSCULAR DISORDERS | WANG, CHANG YU | 29d |
| 19170782 | ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS | VALENROD, YEVGENY | 55d |
| 18783046 | LETTUCE VARIETY 'SUNBERG’ | ZHONG, WAYNESHAOBIN | 65d |
| 19131469 | A SPINACH PLANT RESISTANT TO DOWNY MILDEW AND A RESISTANCE GENE | DEVEAU ROSEN, JASON | — |
| 19052818 | LETTUCE VARIETIES ‘EZTREME’ AND ‘NIGHTHAWK’ | ZHONG, WAYNESHAOBIN | — |
| Art Unit | Apps |
|---|---|
| 1663 | 9 |
| 1651 | 7 |
| 1642 | 7 |
| 1628 | 6 |
| 1612 | 6 |
| 1627 | 6 |
| 1626 | 6 |
| 1662 | 5 |
| 3783 | 5 |
| 1629 | 5 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19386955 | Untitled | President and Fellows of Harvard College | GORDON, MELENIE LEE | 1651 | §103§112Other | Non-Final OA | — | Pending | |
| 19371802 | Methods of Treating Red Blood Cell Disorders | DANA-FARBER CANCER INSTITUTE, INC. | ABBAS, SYED JARAR | 1674 | §103§112 | Non-Final OA | — | Pending | Oct 28, 2025 |
| 19304291 | HYBRID TOMATO VARIETIES 'E15C42784', 'E15C42790', AND 'E15C42808' | Enza Zaden Beheer B.V. | LOGSDON, CHARLES | §112Other | Non-Final OA | — | Pending | Aug 19, 2025 | |
| 19131469 | A SPINACH PLANT RESISTANT TO DOWNY MILDEW AND A RESISTANCE GENE | Enza Zaden Beheer B.V. | DEVEAU ROSEN, JASON | 1662 | §112 | Non-Final OA | — | Pending | May 20, 2025 |
| 19170782 | ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS | Amazentis SA | VALENROD, YEVGENY | 1628 | §103 | Non-Final OA | 55d | Pending | Apr 04, 2025 |
| 19170838 | METHODS FOR AUTOMATING THE PROMPTING AND POST-PROCESSING OF AI SYSTEMS FOR INTERPRETATION AND REPORTING OF PUBLIC SAFETY DATA, STATISTICS, AND CONTEXTUAL KNOWLEDGE | Simsi, Inc. | PADUA, NICO LAUREN | 3626 | §101§103 | Non-Final OA | 11d overdue | Pending | Apr 04, 2025 |
| 19085331 | HYBRID CUCUMBER "E23B.2448" | Enza Zaden Beheer B.V. | MCWILLIAMS, KELSEY LYNN | §112 | Non-Final OA | — | Pending | Mar 20, 2025 | |
| 19080090 | RETRACTABLE MOLD BUILT-IN PRECISION PINS TO LOCATE COMPONENTS DURING LAYUP PROCESS FOR FABRICATION OF WIND TURBINE BLADES | Tpi Technology Inc. | DANIELS, MATTHEW J | §103§112 | Non-Final OA | — | Pending | Mar 14, 2025 | |
| 19074044 | FORMULATIONS FOR NEOPLASIA VACCINES | The Broad Institute, Inc. | HALVORSON, MARK | 1646 | §112 | Final Rejection | 5d | Pending | Mar 07, 2025 |
| 19052818 | LETTUCE VARIETIES ‘EZTREME’ AND ‘NIGHTHAWK’ | Enza Zaden Beheer B.V. | ZHONG, WAYNESHAOBIN | §112 | Non-Final OA | — | Pending | Feb 13, 2025 | |
| 19044079 | SYSTEMS AND METHODS FOR MANAGING RESOURCE UTILIZATION IN CLOUD INFRASTRUCTURE | Connectwise, LLC | ALRIYASHI, ABDULKADER MOHAMED | §101Other | Non-Final OA | — | Pending | Feb 03, 2025 | |
| 19028700 | ROOT INSERT STOPPER FASTENING EQUIPMENT | Tpi Technology, Inc. | COOK, KYLE A | 3726 | §112 | Non-Final OA | 46d overdue | Pending | Jan 17, 2025 |
| 19028103 | HYBRID TOMATO VARIETY 'E15C43080' | Enza Zaden Beheer B.V. | KUMAR, VINOD | §101§102§103§112 | Non-Final OA | — | Pending | Jan 17, 2025 | |
| 19004872 | SYSTEMS AND METHODS FOR CONVERTING SALES OPPORTUNITIES TO SERVICE TICKETS, SALES ORDERS, AND PROJECTS | Connectwise, LLC | JEANTY, ROMAIN | 3624 | §101§102DP | Non-Final OA | — | Pending | Dec 30, 2024 |
| 18987408 | HYBRID TOMATO VARIETIES 'E15A43013', 'E15B43148', ‘E15B43155’, AND ‘E15C42988’ | Enza Zaden Beheer B.V. | PAGE, BRENT T | 1663 | §112 | Non-Final OA | — | Pending | Dec 19, 2024 |
| 18977008 | VACCINES COMPRISING METHANOBREVIBACTER GOTTSCHALKII | Arkea Bio Corp. | FOLEY, SHANON A | 1671 | §103§112 | Non-Final OA | 264d overdue | Pending | Dec 11, 2024 |
| 18863566 | IMMUNOBIOTICS FOR PREVENTING BACTERIAL PNEUMONIA AND METHODS OF USING THE SAME | The Regents of the University of Colorado | OGUNBIYI, OLUWATOSIN A | §102§103§112 | Non-Final OA | — | Pending | Nov 06, 2024 | |
| 18933600 | CENTRALIZED CLOUD SERVICE MANAGEMENT | Connectwise, LLC | ALMANI, MOHSEN | 2159 | §103 | Non-Final OA | 17d overdue | Pending | Oct 31, 2024 |
| 18861976 | CHEST BOLT AND THORACOSTOMY BOLT | Spinthyr Technologies, LLC | LONG, SARAH A | 3771 | §102§103§112 | Final Rejection | 28d overdue | Pending | Oct 31, 2024 |
| 18927310 | ANIMAL POSITIONING AND MONITORING SYSTEM FOR MICROSCOPY | Northeastern University | MORALES, JON ERIC C | 3786 | §102 | Non-Final OA | — | Pending | Oct 25, 2024 |
| 18915785 | DYNAMIC MIXING AND DELIVERY SYSTEM FOR MIXING A THERAPEUTIC AGENT IN AN INJECTOR OR AUTOINJECTOR | Windgap Medical, Inc. | DIOP, FATIMATA SAHRA | 3783 | §102§103§112Other | Non-Final OA | — | Pending | Oct 15, 2024 |
| 18913578 | ARCHITECTURES OF LARGE LANGUAGE MODELS FOR MEDICAL TREATMENT DECISION SUPPORT | Trialmatch.Me, Inc. D/B/A/Trialjectory | ZHU, RICHARD Z | 2654 | §103 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18905355 | HYBRID TOMATO VARIETIES 'E15A43014', 'E15B42750', AND 'E15M43066' | Enza Zaden Beheer B.V. | SHARMA, SANTOSH | 1663 | §112 | Non-Final OA | — | Pending | Oct 03, 2024 |
| 18900073 | INDIVIDUALIZED GENERATIVE MODELS FOR IMAGE GENERATION AND MANIPULATION | The University of Chicago | RACHEDINE, MOHAMMED | §101§103 | Non-Final OA | — | Pending | Sep 27, 2024 | |
| 18897839 | STYLUS DERIVED METRICS TO DETECT CENTRAL AND PERIPHERAL NERVOUS SYSTEM ATTRIBUTES | Linus Health, Inc. | OGLES, MATTHEW ERIC | 3792 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18886527 | HYBRID TOMATO VARIETIES 'E15T43109' AND 'E15T43110' | Enza Zaden Beheer B.V. | KUMAR, VINOD | 1663 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 16, 2024 |
| 18845749 | LIPID NANOPARTICLES FOR TARGETED DELIVERY OF MRNA | Trustees Of Tufts College | SONG, JIANFENG | 1613 | §102DP | Non-Final OA | — | Pending | Sep 10, 2024 |
| 18841884 | COMPOSITIONS COMPRISING AN ACTIVE INGREDIENT MIXTURE COMPRISING SILICON AND BIOTIN AND METHODS OF USE | Nutrition21, LLC | PALENIK, JEFFREY T | §102 | Non-Final OA | — | Pending | Aug 27, 2024 | |
| 18812309 | THERAPEUTIC ALKALOID COMPOUNDS | Sensorium Therapeutics, Inc. | ROZOF, TIMOTHY R | §102DP | Non-Final OA | — | Pending | Aug 22, 2024 | |
| 18799720 | METHOD FOR PRODUCING A COATED PERFORATED STEEL STRIP | Voestalpine Stahl GmbH | PENNY, TABATHA L | 1712 | §103 | Final Rejection | — | Pending | Aug 09, 2024 |
| 18836191 | WATER-SOLUBLE HETEROCYCLYL POLYMETHINE CHROMOPHORES | The Regents of the University of California | JACKSON, SHAWQUIA | 1629 | §102§112 | Non-Final OA | — | Pending | Aug 06, 2024 |
| 18790836 | EXTENSIBILITY NETWORKING LAYER OF AN INTEGRATION SYSTEM | Connectwise, LLC | NGUYEN, HAO HONG | 2447 | §103 | Final Rejection | 70d | Pending | Jul 31, 2024 |
| 18790846 | CREATING AN INTEGRATION AT A VENDOR LAYER | Connectwise, LLC | GURMU, MULUEMEBET | 2163 | §103 | Final Rejection | — | Pending | Jul 31, 2024 |
| 18783046 | LETTUCE VARIETY 'SUNBERG’ | Enza Zaden Beheer B.V. | ZHONG, WAYNESHAOBIN | 1662 | §112 | Non-Final OA | 65d | Pending | Jul 24, 2024 |
| 18778356 | LETTUCE VARIETY 'E01G11679' | Enza Zaden Beheer B.V. | BYRNES, DAVID R | 1662 | §112 | Final Rejection | 38d overdue | Pending | Jul 19, 2024 |
| 18730197 | SENSITIVE AND ACCURATE FEATURE VALUES FROM DEEP MALDI SPECTRA | BIODESIX, INC. | WANG, JING | §101§112 | Non-Final OA | — | Pending | Jul 18, 2024 | |
| 18768496 | TREATMENT OF MIGRAINE | Allergan Pharmaceuticals International Limited | ROZOF, TIMOTHY R | §103DP | Non-Final OA | — | Pending | Jul 10, 2024 | |
| 18724189 | ACIDIC SALT OR CRYSTAL FORM OF NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Changzhou Hansoh Pharmaceutical Co., Ltd. | BRAUN, MADELINE E | §103§112DP | Non-Final OA | — | Pending | Jun 25, 2024 | |
| 18722003 | BIFUNCTIONAL SULPHONAMIDE COMPOUNDS | Anaxis Pharma Pty Ltd | KOSTURKO, GEORGE W | §112 | Non-Final OA | — | Pending | Jun 20, 2024 | |
| 18722389 | LETTUCE PLANT RESISTANT TO DOWNY MILDEW AND RESISTANCE GENE | Enzazaden Beheer B.V. | ORDAZ, CHRISTIAN JOSE | 1663 | §112 | Final Rejection | — | Pending | Jun 20, 2024 |
| 18746393 | BIOACTIVE PEPTIDES AND METHODS OF USE THEREOF | Op-T LLC | CHESTNUT, BARRY A | §103DP | Non-Final OA | — | Pending | Jun 18, 2024 | |
| 18744204 | OBFUSCATING ANALOG CIRCUITS USING SWITCHED PHASE CIRCUITS | Northeastern University | ANDERSON, MICHAEL D | 2433 | §103 | Final Rejection | — | Pending | Jun 14, 2024 |
| 18741322 | COMPOSITIONS AND METHODS FOR TREATING CANCER | The Regents of the University of California | CHICKS, ASHLI ARIANA | Other | Non-Final OA | — | Pending | Jun 12, 2024 | |
| 18714670 | DIAGNOSTIC TEST | Apis Assay Technologies Ltd. | KENNEDY, SARAH JANE | §101§102 | Non-Final OA | — | Pending | May 30, 2024 | |
| 18712988 | SUBAMBIENT DAYTIME COOLING ENABLED BY HIERARCHICALLY ARCHITECTED ALL-INORGANIC METAPAPER WITH ENHANCED THERMAL DISSIPATION | Northeastern University | CALANDRA, ANTHONY J | 1748 | §102§103§112 | Non-Final OA | 10d overdue | Pending | May 23, 2024 |
| 18712285 | INDOLINES AS PROTAC COMPOUNDS | Neophore Limited | SHI, GENBIN | §103 | Non-Final OA | — | Pending | May 22, 2024 | |
| 18712311 | ISOINDOLINES AS PMS2 INHIBITORS | Neophore Limited | NOLAN, JASON MICHAEL | §112 | Non-Final OA | — | Pending | May 22, 2024 | |
| 18670099 | PERISTALTIC PUMPING OF FLUIDS AND ASSOCIATED METHODS, SYSTEMS, AND DEVICES | Quantum-Si Incorporated | KASTURE, DNYANESH G | 3746 | §102§103§112 | Non-Final OA | 15d overdue | Pending | May 21, 2024 |
| 18669928 | SYNTHETIC FUELS, AND METHODS AND APPARATUS FOR PRODUCTION THEREOF | Air Company Holdings, Inc. | PO, MING CHEUNG | 1771 | §103 | Final Rejection | — | Pending | May 21, 2024 |
| 18710091 | COMPOSITIONS AND METHODS FOR PRESERVING AND/OR RESTORING NEURAL FUNCTION | The Regents of the University of California | MCANANY, JOHN D | §102§103§112DP | Non-Final OA | — | Pending | May 14, 2024 | |
| 18654512 | LETTUCE VARIETIES ‘E01C11866’, ‘E01L30616’ AND ‘E01B11959’ | Enza Zaden Beheer B.V. | DEVEAU ROSEN, JASON | 1662 | §112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18649438 | USE OF ACIDIC ELECTROLYTE CATIONS FOR SELECTIVE ELECTROCHEMICAL CO2 AND CO CONVERSIONS TO METHANOL | Massachusetts Institute Of Technology | WONG, EDNA | 1795 | §103§112 | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18647310 | IMIDAZOLE-CONTAINING INHIBITORS OF ALK2 KINASE | Biocryst Pharmaceuticals, Inc. | CORNET, JEAN P | DP | Non-Final OA | — | Pending | Apr 26, 2024 | |
| 18702703 | GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 3 | Prime Medicine, Inc. | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §103§112 | Non-Final OA | — | Pending | Apr 18, 2024 |
| 18635442 | PERICELLULAR OXYGEN-CONTROLLING CELL CULTURE INCUBATOR | Northeastern University | HAQ, SHAFIQUL | §103 | Non-Final OA | — | Pending | Apr 15, 2024 | |
| 18627964 | SYSTEMS AND METHODS FOR MOBILE SPEECH HEARING OPTIMIZATION | Linus Health, Inc. | ROBERTS, ANNA L | 3791 | §101§102§103§112 | Non-Final OA | 4d overdue | Pending | Apr 05, 2024 |
| 18608002 | METHODS FOR ESTIMATING AND SERVING WAKE WINDOW PREDICTIONS BASED ON SLEEP DATA | Huckleberry Labs, Inc. | WILLOUGHBY, ALICIA M | §101§103§112 | Non-Final OA | — | Pending | Mar 18, 2024 | |
| 18608256 | MODULAR SEMI-SUBMERSIBLE OFFSHORE PLATFORM | Aikido Technologies, Inc. | VENNE, DANIEL V | 3615 | §101§102§103§112Other | Non-Final OA | — | Pending | Mar 18, 2024 |
| 18690382 | SUBSTRATES AND BIOMARKERS OF ADAMTS7 | The Broad Institute, Inc. | PAGUIO FRISING, MICHELLE F | 1651 | §112 | Non-Final OA | — | Pending | Mar 08, 2024 |
| 18596170 | TECHNIQUES FOR REAL-TIME RESPONSE STRATEGIES IN A SUPPLY CHAIN | Cognosos, Inc. | EL-BATHY, IBRAHIM N | 3628 | §101 | Non-Final OA | 31d overdue | Pending | Mar 05, 2024 |
| 18688196 | METHODS FOR THE PREVENTION AND TREATMENT OF SYNUCLEINOPATHIES | Vaxxinity, Inc. | WANG, CHANG YU | §103 | Non-Final OA | — | Pending | Feb 29, 2024 | |
| 18687436 | METHODS FOR THE GENERATION OF HUMAN RETINAL GANGLION CELLS AND COMPOSITIONS, ASSAYS, DEVICES, AND KITS COMPRISING SAME | Albert Einstein College of Medicine | BARRON, SEAN C | 1653 | §103§112 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18683663 | RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEIN | Trustees Of Tufts College | LIPPERT, JOHN WILLIAM | §103 | Non-Final OA | — | Pending | Feb 14, 2024 | |
| 18440188 | CLEAVABLE LINKER-CONTAINING IONIZABLE LIPIDS AND LIPID CARRIERS FOR THERAPEUTIC COMPOSITIONS | Flagship Pioneering Innovations Vii, LLC | HOLLOMAN, NANNETTE | 1612 | §102§103 | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18437633 | NON-PROTEIN CLOSTRIDIAL TOXIN COMPOSITIONS | Allergan, Inc. | BERKE-SCHLESSEL, DAVID W | 1651 | §103§112Other | Non-Final OA | — | Pending | Feb 09, 2024 |
| 18682544 | WOUND MONITORING SYSTEM AND SENSOR THEREOF | National University Of Singapore | WESTFALL, SARAH ANN | 3791 | §102§103§112 | Non-Final OA | 26d | Pending | Feb 09, 2024 |
| 18431448 | PARAMETRIC AND AUTOMATED TOOL FOR THE DESIGN OF STEEL SUBSTRUCTURE OF COMPOSITE MOLDS | Tpi Technology, Inc. | ARTHUR JEANGLAUDE, GERTRUDE | 3661 | §102§103 | Non-Final OA | 9d | Pending | Feb 02, 2024 |
| 18431278 | DUAL CAP SYSTEM FOR CONTAINER-CLOSURES TO MAINTAIN TIP STERILITY DURING SHELF STORAGE | Allergan, Inc. | DAVISON, LAURA L | 3993 | §103Other | Non-Final OA | 22d | Pending | Feb 02, 2024 |
| 18427141 | RESISTANCE GENE AND LETTUCE PLANT RESISTANT TO DOWNY MILDEW | Enza Zaden Beheer B.V. | BYRNES, DAVID R | 1662 | §112DP | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18420205 | AORTIC PROSTHESIS WITH TUNNEL GRAFT AND EMBOLIC FILTER | Bolton Medical, Inc. | HOUSTON, ELIZABETH | 3771 | §103 | Non-Final OA | — | Pending | Jan 23, 2024 |
| 18413789 | BLOCKCHAIN-BASED PLATFORM FOR HEALTH RECORD EXCHANGE | Blue Cross And Blue Shield Of Massachusetts, Inc. | EDOUARD, JONATHAN CHRISTOPHER | 3683 | §101§103 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18576696 | COMPOSITIONS AND METHODS FOR DECREASING PIGMENTATION | The General Hospital Corporation | GREENE, IVAN A | 1619 | §102§103 | Non-Final OA | — | Pending | Jan 04, 2024 |
| 18575007 | SYSTEM AND METHOD FOR CONTACTLESS DRINK DISPENSING | Backbar Solutions | PANCHOLI, VISHAL J | 3754 | §103 | Non-Final OA | 32d overdue | Pending | Dec 28, 2023 |
| 18573519 | TETRACYCLINE DERIVATIVE-INDUCED MITOHORMESIS MEDIATES DISEASE TOLERANCE AGAINST VIRAL INFECTIONS | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | SHAMEEM, GOLAM M | 1621 | §102§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18570787 | SMALL MOLECULE DISRUPTORS OF PROTEIN INTERACTIONS IN HISTONE DEACETYLASE COMPLEXES | University Of Liege | DAHLIN, HEATHER RAQUEL | 1629 | §101§102§103 | Non-Final OA | — | Pending | Dec 15, 2023 |
| 18570244 | INHIBITOR COMPOUNDS | Neophore Limited | NESTOR, DONNA MICHELLE | 1627 | §103§112Other | Non-Final OA | 15d overdue | Pending | Dec 14, 2023 |
| 18568771 | HETEROCYCLIC JAK INHIBITOR | BEIJING INNOCARE PHARMA TECH CO., LTD. | YOO, SUN JAE | 1621 | §112 | Non-Final OA | — | Pending | Dec 08, 2023 |
| 18532636 | TREATMENT OF GRAFT-VERSUS-HOST DISEASE WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | The Regents of the University of California | ANDERSON, REBECCA L | 1626 | §112 | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18532632 | TREATMENT OF MYELOPROLIFERATIVE DISEASES AND DISORDERS WITH INHIBITORS OF BET FAMILY BDII BROMODOMAIN | Poseidon Innovation 1, Inc. | ANDERSON, REBECCA L | 1626 | §102§103§112Other | Non-Final OA | — | Pending | Dec 07, 2023 |
| 18526510 | CAPPED SYRINGES AND METHODS OF SEALING SAME | Discgenics, Inc. | FAROOQ, MAHMOOD | 3783 | §102§103 | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18526900 | NUCLEAR TRANSPORT MODULATORS AND USES THEREOF | Karyopharm Therapeutics Inc. | RODRIGUEZ-GARCIA, VALERIE | 1621 | §103Other | Non-Final OA | — | Pending | Dec 01, 2023 |
| 18565721 | MINERALOCORTICOID RECEPTOR ANTAGONISTS FOR THE PREVENTION AND/OR TREATMENT OF A CORONAVIRUS INFECTION | Imaginatives Group Limited | BARSKY, JARED | 1628 | §102§103§112 | Non-Final OA | 23d overdue | Pending | Nov 30, 2023 |
| 18564384 | CANCER THERAPY USING A COMBINATION OF CDK7 INHIBITOR WITH AN ANTI-CANCER AGENT | Aurigene Discovery Technologies Limited | ROMERO, KRISTEN WANG | 1624 | §112Other | Non-Final OA | 8d overdue | Pending | Nov 27, 2023 |
| 18563294 | METHOD FOR MONITORING PANCREATIC BETA-CELL DESTRUCTION IN DISEASE PREDICTION/DIAGNOSIS/PROGNOSIS OF TYPE 2 DIABETES MELLITUS | Ekaterini Chatzaki | GEDRA, OLIVIA ROSE | 3681 | §101§103 | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18562719 | MPLA COMPOSITIONS AND METHODS OF USE | Revelation Biosciences, Inc. | TIEN, LUCY MINYU | 1612 | DP | Final Rejection | 17d overdue | Pending | Nov 20, 2023 |
| 18561805 | ROBUST, HIGH-THERMAL CONDUCTANCE, CAPILLARITY-ENABLED THIN-FILM DRY CONDENSING SURFACES | Massachusetts Institute Of Technology | NOUKETCHA, LIONEL W | 3700 | §103 | Final Rejection | — | Pending | Nov 17, 2023 |
| 18289836 | Targeting Extracellular Matrix Proteins to Regulate NK Cell Function in Peripheral Tissues | The General Hospital Corporation | PRIEST, JESSICA MARIE | 1642 | §102§112Other | Non-Final OA | — | Pending | Nov 07, 2023 |
| 18288871 | HUMANIZED ANTI-PSMA ANTIBODY | Institute Of Biotechnology Cas, V.V.I. | SKOKO III, JOHN JOSEPH | 1643 | §112 | Non-Final OA | — | Pending | Oct 30, 2023 |
| 18491049 | DUAL STRAND NUCLEIC ACID-GUIDED NICKASE EDITING | Inscripta, Inc. | MONTANARI, DAVID A | 1632 | Other | Non-Final OA | 10d overdue | Pending | Oct 20, 2023 |
| 18287784 | METHODS OF PREPARING AN EXTRACORPOREAL CIRCUIT FOR ANTICOAGULATION | Lawell Therapeutics, LLC | DEAK, LESLIE R | 3799 | §102 | Final Rejection | 3d overdue | Pending | Oct 20, 2023 |
| 18381910 | ASSESSING JOINT CONDITION USING ACOUSTIC SENSORS | Kneevoice, Inc. | FERNANDES, PATRICK M | 3791 | §101§103§112Other | Non-Final OA | 19d overdue | Pending | Oct 19, 2023 |
| 18287229 | LIPID NANOPARTICLES COMPOSITIONS | Intellia Therapeutics, Inc. | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §102§103DP | Non-Final OA | — | Pending | Oct 17, 2023 |
| 18286615 | BICYCLIC HETEROAROMATIC INHIBITORS OF KLK5 | Biocryst Pharmaceuticals, Inc. | MAHLUM, JONATHAN DAVIS | 1625 | §103 | Non-Final OA | — | Pending | Oct 12, 2023 |
| 18375713 | IMPLANT | Inflammasome Therapeutics, Inc. | KIM, DANIELLE A | 1613 | §103 | Final Rejection | — | Pending | Oct 02, 2023 |
| 18284921 | BATTERY | Eternity Technologies Limited | YANCHUK, STEPHEN J | 1752 | §103 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18374983 | HYBRID PEPPER VARIETY 'E20S0465' | Enza Zaden Beheer B.V. | FAN, WEIHUA | 1663 | §112 | Non-Final OA | — | Pending | Sep 29, 2023 |
| 18473740 | ORAL CARE COMPOSITIONS COMPRISING GERANYLGERANIOL AND METHODS OF USE THEREOF | American River Nutrition, LLC | GEMBEH, SHIRLEY V | 1615 | §103 | Non-Final OA | — | Pending | Sep 25, 2023 |
| 18281138 | SMALL MOLECULE INHIBITORS OF MAMMALIAN SLC6A19 FUNCTION | Jnana Therapeutics Inc. | JACKSON, SHAWQUIA | 1626 | §103Other | Final Rejection | — | Pending | Sep 08, 2023 |
| 18281045 | NOVEL CELL THERAPY SYSTEM | Biosceptre ( Aust ) Pty Ltd. | JOHANSEN, PETER N. | 1644 | §103§112 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18280593 | SMART MECHANICAL METAMATERIALS WITH TUNABLE STIMULI-RESPONSIVE EXPANSION COEFFICIENTS | Northeastern University | EWALD, MARIA VERONICA | 1783 | §103§112 | Final Rejection | 35d overdue | Pending | Sep 06, 2023 |
| 18279988 | COMPOSITIONS AND METHODS FOR TREATMENT OF BLEPHARITIS | Voom, LLC | STOCKTON, LAURA LYNNE | 1626 | §102§103 | Non-Final OA | — | Pending | Sep 01, 2023 |
| 18240550 | METHODS FOR INCREASED NUCLEIC ACID-GUIDED CELL EDITING | Inscripta, Inc. | BRETZ, COREY LANE | 1635 | §102§103 | Non-Final OA | 3d overdue | Pending | Aug 31, 2023 |
| 18278995 | COMPOSITIONS AND METHODS FOR MONITORING ENPP1 ACTIVITY | The Regents of the University of California | LANKFORD JR, LEON B | 1657 | §112 | Non-Final OA | — | Pending | Aug 25, 2023 |
| 18238261 | COMPOSITIONS AND METHODS FOR TREATING TYPE 2 DIABETES USING GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) | The Regents of the University of Colorado | LEE, JIA-HAI | 1658 | §101§102§103§112DPOther | Non-Final OA | 75d | Pending | Aug 25, 2023 |
| 18547760 | NONAUTOLOGOUS MULTI-STRESSED CANCER CELLS AND USES THEREOF FOR VACCINATING AND TREATING CANCERS | Brenus Pharma | MARTIN, PAUL C | 1653 | §103§112DP | Non-Final OA | — | Pending | Aug 24, 2023 |
| 18234690 | RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX | The University of Tokyo | ZARA, JANE J | 1637 | §112 | Final Rejection | 9d overdue | Pending | Aug 16, 2023 |
| 18277522 | COMPOSITIONS AND METHODS FOR TREATING TAUOPATHIES | The Regents of the University of California | WARD, PAUL V | 1622 | §102§112 | Non-Final OA | — | Pending | Aug 16, 2023 |
| 18234342 | SYSTEMS AND METHODS FOR CELL MANUFACTURING | Cellino Biotech, Inc. | NOBLE, MARCIA STEPHENS | 1632 | §102§103§112Other | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18276802 | CXCR4-LIGANDS FOR DIAGNOSTIC AND THERAPEUTIC USE AND PRECURSORS THEREOF | Technische Universität München | RONEY, CELESTE A | 1612 | §103§112DP | Non-Final OA | — | Pending | Aug 10, 2023 |
| 18276721 | SCALABLE, FIRE-RESISTANT, AND SPECTRALLY ROBUST MELAMINE-FORMALDEHYDE PHOTONIC BULK FOR EFFICIENT DAYTIME RADIATIVE COOLING | Northeastern University | HINES, LATOSHA D | 1771 | §112 | Non-Final OA | 9d overdue | Pending | Aug 10, 2023 |
| 18230480 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | The Regents of the University of California | WEIDNER, ADAM M | 1675 | §103 | Final Rejection | 10d overdue | Pending | Aug 04, 2023 |
| 17881302 | METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTONS TYROSINE KINASE | Pharmacyclics LLC | SCHMITT, MICHAEL J | 1629 | §103 | Non-Final OA | 38d overdue | Pending | Aug 04, 2023 |
| 18226590 | UROLITHIN DERIVATIVES AND THERAPEUTIC USES | Vandria SA | DROUIN, STEVE HOANG | 1627 | §102§103 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18226621 | THERAPEUTIC USES OF UROLITHIN DERIVATIVES | Vandria SA | WARD, PAUL V | 1622 | §102 | Non-Final OA | — | Pending | Jul 26, 2023 |
| 18273466 | T CELL-DIRECTED ANTI-CANCER VACCINES AGAINST COMMENSAL VIRUSES FOR TREATING MUCOSAL CARCINOMAS | The General Hospital Corporation | JADHAO, SAMADHAN JAISING | 1672 | §102§103§112DP | Non-Final OA | — | Pending | Jul 20, 2023 |
| 17926847 | ANTIVIRAL POLYMERS | The University of Manchester | PIPIC, ALMA | 1617 | §103 | Final Rejection | 25d overdue | Pending | Jul 19, 2023 |
| 18272697 | AZAQUINAZOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING DIROFILARIA INFECTION IN A MAMMAL | The University of Liverpool | RAO, PADMAJA S | 1627 | §103§112Other | Non-Final OA | 28d | Pending | Jul 17, 2023 |
| 18272184 | METHODS AND COMPOSITIONS FOR IDENTIFYING NEUROENDOCRINE PROSTATE CANCER | DANA-FARBER CANCER INSTITUTE, INC. | DAUNER, JOSEPH G | 1682 | §101§102§103§112 | Non-Final OA | 63d | Pending | Jul 13, 2023 |
| 18271913 | PHARMACEUTICAL FORMULATION | Redx Pharma PLC | CHANG, KYUNG SOOK | 1613 | §103 | Final Rejection | — | Pending | Jul 12, 2023 |
| 18221140 | MITOCHONDRIA-TARGETING PEPTIDES | Stealth BioTherapeutics Inc. | OTTON, ALICIA L | 1699 | §103§112 | Non-Final OA | 55d | Pending | Jul 12, 2023 |
| 18271918 | QUANTUM COMPUTING SYSTEM AND METHOD | Odyssey Therapeutics UK Limited | GOODCHILD, WILLIAM J | 2433 | §102§103 | Non-Final OA | 6d | Pending | Jul 12, 2023 |
| 18271503 | PRODUCTS AND METHODS FOR PROMOTING MYOGENESIS | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | PAULUS, ERIN VIRGINIA | 1631 | §103 | Final Rejection | 4d overdue | Pending | Jul 10, 2023 |
| 18269869 | HEPATOCELLULAR CARCINOMA TREATMENTS, PROPHYLACTIC THERAPIES, AND COMPOSITIONS FOR USE THEREWITH | Repair Biotechnologies, Inc. | IANNUZO, NATALIE NMN | 1653 | §102§103 | Final Rejection | 50d overdue | Pending | Jun 27, 2023 |
| 18269168 | COMPOSITIONS AND METHODS RELATED TO BICYCLO[2.2.1] HEPTANAMINE-CONTAINING COMPOUNDS | The Brigham And Women'S Hospital, Inc. | OH, TAYLOR V | 1625 | §102§103 | Final Rejection | — | Pending | Jun 22, 2023 |
| 18268688 | DOSING REGIMENS FOR ORAL ALK2 KINASE INHIBITORS | Biocryst Pharmaceuticals, Inc. | HERNANDEZ, JACKSON J | 1627 | §103Other | Final Rejection | 56d | Pending | Jun 21, 2023 |
| 18268102 | METHODS OF TREATING NEURODEGENERATIVE DISORDERS AND STAT3-LINKED CANCERS USING SUPPRESSORS OF ELECTRON LEAK | Cornell University | MARTIN, KEVIN STEPHEN | 1624 | §103§112 | Final Rejection | 6d | Pending | Jun 16, 2023 |
| 18268050 | APPARATUS AND METHOD FOR CONVERTING CARBON DIOXIDE TO SUGARS | Air Company Holdings, Inc. | RAJA, JAANZEB CHAANGEZ | 1736 | §102§103 | Non-Final OA | — | Pending | Jun 16, 2023 |
| 18257962 | COCRYSTAL OF A CDK INHIBITOR | Aurigene Discovery Technologies Limited | LEE, CHIHYI NMN | 1628 | §103§112Other | Non-Final OA | — | Pending | Jun 16, 2023 |
| 17769173 | REACTIVE AFFINITY PROBE-INTERACTION DISCOVERY PLATFORM | Jnana Therapeutics Inc. | DAUNER, JOSEPH G | 1682 | §103§112 | Final Rejection | 22d overdue | Pending | Jun 15, 2023 |
| 18209299 | ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN ROR1 AND USE FOR THE SAME | Abl Bio, Inc. | HOPKINS, SAMANTHA LAKE | 1641 | §112DP | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18266486 | USE OF VACCINE COMPOSITIONS BASED ON SARS-COV-2 RECEPTOR BINDING DOMAIN IN DELIVERING PROTECTIVE IMMUNITY | Centro De Inmunología Molecular | CHEN, STACY BROWN | 1672 | §102§103§112 | Non-Final OA | 35d overdue | Pending | Jun 09, 2023 |
| 18256277 | COMPOSITIONS AND METHODS FOR MUCOSAL DRUG DELIVERY | The Schepens Eye Research Institute, Inc. | HELM, CARALYNNE E | 1615 | §103§112 | Final Rejection | — | Pending | Jun 07, 2023 |
| 18206368 | LETTUCE VARIETIES 'EZFLOR', 'BAUER', AND 'ADICAMP' | Enza Zaden Beheer B.V. | FAN, WEIHUA | 1663 | §112 | Final Rejection | 23d overdue | Pending | Jun 06, 2023 |
| 18265561 | LIPIDOID COMPOSITIONS AND METHODS OF USE THEREOF | Trustees Of Tufts College | KAMM, JUDITH MARIE | 1637 | §103§112DP | Non-Final OA | — | Pending | Jun 06, 2023 |
| 18265380 | COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES | Annexon, Inc. | ABBAS, SYED JARAR | 1674 | §102§112 | Non-Final OA | 44d overdue | Pending | Jun 05, 2023 |
| 18265368 | USE OF SYNTHETIC COPOLYPEPTIDE HYDROGELS AS DERMAL FILLERS | The Regents of the University of California | LEE, JIA-HAI | 1658 | §103§112DP | Non-Final OA | — | Pending | Jun 05, 2023 |
| 18205305 | ENHANCING AUTOPHAGY OR INCREASING LONGEVITY BY ADMINISTRATION OF UROLITHINS | Amazentis SA | VALENROD, YEVGENY | 1628 | §103 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18265086 | TRANSGENIC ANIMAL HAVING MODIFIED MYOSTATIN GENE | Kyungsangbukdo | WILSON, MICHAEL C | 1638 | §103§112 | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18205096 | LIPID-LIKE NANOCOMPLEXES AND USES THEREOF | Trustees Of Tufts College | ANTHOPOLOS, PETER | 1611 | §103Other | Non-Final OA | — | Pending | Jun 02, 2023 |
| 18204492 | TREATMENT OF POST-OPERATIVE JOINT PAIN WITH POLYSULFATED POLYSACCHARIDES | Paradigm Biopharmaceuticals Ltd. | CHO, DAVID H | 1693 | §103§112Other | Final Rejection | — | Pending | Jun 01, 2023 |
| 18202182 | METHODS AND COMPOSITION FOR TREATING METABOLIC SYNDROME | Zbiotics Company | PRAKASH, SUBBALAKSHMI | 1793 | §103 | Non-Final OA | 28d | Pending | May 25, 2023 |
| 18254120 | METHODS AND SYSTEMS FOR TREATMENT OF INTERVERTEBRAL DISC BY INTRADISCAL MICRO-NEEDLE INSERTION | Discgenics, Inc. | BOSWORTH, KAMI A | 3783 | §102§103§112 | Non-Final OA | 28d | Pending | May 23, 2023 |
| 18316845 | COMPOSITE BATTERY TRAY STRUCTURE | Tpi Composites, Inc. | JACOBSON, SARAH JORDAN | 1785 | §102§103§112 | Non-Final OA | — | Pending | May 12, 2023 |
| 18196536 | HYBRID TOMATO VARIETIES 'E15C42785' AND 'E15C42788' | Enza Zaden Beheer B.V. | BUI, PHUONG T | 1663 | §112 | Final Rejection | 30d overdue | Pending | May 12, 2023 |
| 18035373 | BINDING PROTEINS RECOGNIZING HA-1 ANTIGEN AND USES THEREOF | Tscan Therapeutics, Inc. | LEE, YIE CHIA | 1642 | §101§102§103§112 | Non-Final OA | — | Pending | May 04, 2023 |
| 18035399 | VISTA AGONIST FOR TREATMENT/PREVENTION OF ISCHEMIC AND/OR REPERFUSION INJURY | The Trustees of Dartmouth College | SULLIVAN, DENNIS JOHN | 1642 | §103§112Other | Non-Final OA | 37d overdue | Pending | May 04, 2023 |
| 18034202 | COMPOSITIONS COMPRISING SPIRULINA COMPONENTS | Evelo Biosciences, Inc. | ARIANI, KADE | 1651 | §101§102§103 | Non-Final OA | 29d | Pending | Apr 27, 2023 |
| 18033492 | ENHANCED HYT-INDUCED PROTEIN DEGRADATION USING LIPID NANOPARTICLE DELIVERY | Trustees Of Tufts College | ARMATO JR, DENNIS IGNATIUS | 1651 | §103§112 | Non-Final OA | 41d | Pending | Apr 24, 2023 |
| 18303533 | SITE SPECIFIC GENETIC ENGINEERING UTILIZING TRANS-TEMPLATE RNAS | Massachusetts Institute Of Technology | GROOMS, TIFFANY NICOLE | 1637 | §103Other | Non-Final OA | 3d overdue | Pending | Apr 19, 2023 |
| 18301732 | GENOMIC EDITING WITH SITE-SPECIFIC RETROTRANSPOSONS | Massachusetts Institute Of Technology | ALLEN, SARAH ELIZABETH | 1637 | §102§103§112Other | Non-Final OA | 26d | Pending | Apr 17, 2023 |
| 18032067 | SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER | BAYER AKTIENGESELLSCHAFT | HIRAKIS, SOPHIA P | 1623 | §103DP | Final Rejection | 30d overdue | Pending | Apr 14, 2023 |
| 18248922 | SYSTEMS AND METHODS FOR PRODUCTION OF MATERIALS USED IN ADDITIVE MANUFACTURING | Applied Cavitation, Inc. | GRAHAM, ANDREW D | 1742 | §102§103 | Final Rejection | 87d overdue | Pending | Apr 13, 2023 |
| 18132073 | HYBRID PEPPER 'E20S.10382' | Enza Zaden Beheer B.V. | BUI, PHUONG T | 1663 | §112 | Final Rejection | 121d overdue | Pending | Apr 07, 2023 |
| 18127887 | IMAGE QUANTIFICATION SYSTEM FOR ESTIMATION OF VIRAL LOAD BASED ON DETECTION BY RAPID ANTIGEN TEST | Hai Kang Life Corporation Limited | DUNN, MCKENZIE A | 1678 | §103§112 | Final Rejection | 23d overdue | Pending | Mar 29, 2023 |
| 18191495 | SLIDE-LEVEL UNCERTAINTY QUANTIFICATION FOR DEEP LEARNING PREDICTIONS IN DIGITAL HISTOPATHOLOGY | The University of Chicago | AUGER, NOAH ANDREW | 2122 | §101§102§103§112 | Non-Final OA | — | Pending | Mar 28, 2023 |
| 18028286 | METTL3 INHIBITORY COMPOUNDS | Storm Therapeutics Limited | MARTIN, KEVIN STEPHEN | 1624 | §112Other | Final Rejection | — | Pending | Mar 24, 2023 |
| 18027796 | ANTIMICROBIAL AQUEOUS COATINGS AND SEALANTS | Bmg ( British Medical Group) Limited | MAEWALL, SNIGDHA | 1612 | §103 | Final Rejection | — | Pending | Mar 22, 2023 |
| 18027313 | COMPOSITIONS AND METHODS FOR TREATING CANCER | Erasca, Inc. | BURKETT, DANIEL JOHN | 1624 | Other | Final Rejection | 46d overdue | Pending | Mar 20, 2023 |
| 18027003 | SOLID DOSAGE FORMS OF BACTERIA | Evelo Biosciences, Inc. | JACKSON-TONGUE, LAKIA J | 1645 | §103§112 | Non-Final OA | 4d overdue | Pending | Mar 17, 2023 |
| 18123143 | COMPOSITIONS COMPRISING UROLITHINS | Amazentis SA | HEITMEIER, KENDALL NICOLE | 1621 | §103§112 | Non-Final OA | — | Pending | Mar 17, 2023 |
| 18026746 | METHODS OF TREATING AN INDIVIDUAL THAT HAS FAILED AN ANTI-PD-1/ANTI-PD-L1 THERAPY | DANA-FARBER CANCER INSTITUTE, INC. | BENAVIDES, JENNIFER ANN | 1675 | §102§103§112Other | Final Rejection | 18d overdue | Pending | Mar 16, 2023 |
| 18115223 | METHOD OF CALCULATING DIAGNOSTIC SCORE FOR PROSTATE CANCER AND USE THEREOF | Urotech. Co., Ltd. | LIN, JERRY | 1671 | §101DP | Non-Final OA | — | Pending | Feb 28, 2023 |
| 18023594 | COMPOSITIONS AND METHODS FOR TREATING AMYLOID-RELATED CONDITIONS | The Regents of the University of California | SOROUSH, ALI | 1614 | §103 | Final Rejection | 53d overdue | Pending | Feb 27, 2023 |
| 18111251 | Watermelon variety 'RIO GRANDE (E26C.00139)' | Enza Zaden Beheer B.V. | PAGE, BRENT T | 1663 | §112 | Non-Final OA | — | Pending | Feb 17, 2023 |
| 18020473 | POLYMER ELECTROLYTE COMPOSITES | Ecolectro, Inc. | KEELING, ALEXANDER W | 1795 | §103 | Final Rejection | — | Pending | Feb 09, 2023 |
| 18020493 | SUBSTITUTED 1,2,4-OXADIAZOLES AS SMALL MOLECULE INHIBITORS OF UBIQUITIN-SPECIFIC PROTEASE 28 | DANA-FARBER CANCER INSTITUTE, INC. | NOLAN, JASON MICHAEL | 1623 | §103 | Final Rejection | — | Pending | Feb 09, 2023 |
| 18019400 | COMPOSITIONS AND METHODS FOR TREATING DISEASES AND DISORDERS | Curis, Inc. | HSU, GRACE CHING | 1627 | §103 | Non-Final OA | — | Pending | Feb 02, 2023 |
| 17784145 | COMPOSITIONS AND METHODS FOR TREATING NEUROMUSCULAR DISORDERS | The Regents of the University of California | WANG, CHANG YU | 1675 | §102§103§112 | Non-Final OA | 29d | Pending | Feb 01, 2023 |
| 18104051 | NICOTINATE AND NICOTINAMIDE RIBOSIDE-BASED COMPOUNDS AND DERIVATIVES THEREOF | New Frontier Bio, Inc. | ANDERSON, REBECCA L | 1626 | §102§112Other | Final Rejection | — | Pending | Jan 31, 2023 |
| 18103301 | SYSTEMS AND METHODS FOR CARD GAME DATA PROCESSING | Rf Labs, Inc. | D'AGOSTINO, PAUL ANTHONY | 3715 | §103 | Final Rejection | 223d overdue | Pending | Jan 30, 2023 |
| 18007189 | FIRE PROTECTION SYSTEM PIPE FITTINGS | Ipex Usa LLC | LINFORD, JAMES ALBERT | 3679 | §102§103§112 | Final Rejection | 8d overdue | Pending | Jan 27, 2023 |
| 18018207 | ARYL SUBSTITUTED PYRROLO-PYRIDINONES AND THERAPEUTIC USES THEREOF | DANA-FARBER CANCER INSTITUTE, INC. | MARTIN, KEVIN STEPHEN | 1624 | §112 | Final Rejection | 31d overdue | Pending | Jan 26, 2023 |
| 18100885 | HUMANIZED ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF | Annexon, Inc. | DAHLE, CHUN WU | 1641 | §112Other | Non-Final OA | 15d | Pending | Jan 24, 2023 |
| 18017666 | NITROGEN-CONTAINING FUSED RING DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | TOWNSLEY, SARA ELIZABETH | 1629 | §103 | Final Rejection | 71d | Pending | Jan 23, 2023 |
| 18016209 | METHODS AND COMPOSITIONS FOR TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION | DANA-FARBER CANCER INSTITUTE, INC. | REDDIG, PETER J | 1646 | §102§103§112 | Non-Final OA | 73d overdue | Pending | Jan 13, 2023 |
| 18089267 | HUMANIZED RODENTS FOR TESTING THERAPEUTIC AGENTS | Regeneron Pharmaceuticals, Inc. | WILSON, MICHAEL C | 1638 | §103§112 | Final Rejection | — | Pending | Dec 27, 2022 |
| 18069387 | ENGINEERED NUCLEASES AND METHODS OF USE THEREOF | Massachusetts Institute Of Technology | CHONG, KIMBERLY | 1636 | §102§112 | Final Rejection | 26d | Pending | Dec 21, 2022 |
| 18011577 | COMPOSITIONS AND METHODS FOR IDENTIFYING EPITOPES | Tscan Therapeutics, Inc. | AMICK, THOMAS RUSSE | 1638 | §103 | Non-Final OA | — | Pending | Dec 20, 2022 |
| 18084739 | ANTIBODY DRUG CONJUGATES COMPRISING TOXINS WITH POLAR GROUPS AND USES THEREOF | Intocell, Inc. | STONEBRAKER, ALYSSA RAE | 1642 | §102§103§112DP | Non-Final OA | — | Pending | Dec 20, 2022 |
| 18011354 | PRODRUGS OF MITOCHONDRIA-TARGETING OLIGOPEPTIDES | Stealth BioTherapeutics Inc. | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | 26d | Pending | Dec 19, 2022 |
| 18011408 | AMIDO COMPOUNDS | Anaxis Pharma Pty Ltd | JACKSON, SHAWQUIA | 1626 | §102§103§112 | Non-Final OA | 112d overdue | Pending | Dec 19, 2022 |
| 18010864 | SMALL MOLECULE COVALENT ACTIVATORS OF UCP1 | DANA-FARBER CANCER INSTITUTE, INC. | SZNAIDMAN, MARCOS L | 1628 | §102 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 18009826 | SARS-COV-2 IMMUNODOMINANT PEPTIDES AND USES THEREOF | Ahs Hospital Corp. | FORD, VANESSA L | 1674 | — | Non-Final OA | 27d | Pending | Dec 12, 2022 |
| 18009485 | FLUID GEL COMPOSITIONS | The University of Birmingham | FAN, LYNN Y | 1759 | §103§112Other | Non-Final OA | 11d overdue | Pending | Dec 09, 2022 |
| 18009566 | POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS | The University of Birmingham | SHIAO, YIH-HORNG | 1691 | §101§102§112Other | Non-Final OA | 10d overdue | Pending | Dec 09, 2022 |
| 18009144 | FLUID GEL COMPOSITIONS | The University of Birmingham | FAN, LYNN Y | 1759 | §102§103§112Other | Non-Final OA | 11d overdue | Pending | Dec 08, 2022 |
| 18007822 | METHODS OF TREATING A CORONAVIRUS INFECTION | The General Hospital Corporation | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §103 | Non-Final OA | 3d overdue | Pending | Dec 02, 2022 |
| 17927485 | COMPOSITIONS AND METHODS FOR TRANSDIFFERENTIATING CELLS | The Regents of the University of California | ZARA, JANE J | 1637 | §102§103§112 | Non-Final OA | 29d overdue | Pending | Nov 23, 2022 |
| 17927529 | BISPECIFIC MOLECULES FOR SELECTIVELY MODULATING T CELLS | DANA-FARBER CANCER INSTITUTE, INC. | CHATTIN, AMY MARIE | 1643 | §103§112 | Non-Final OA | 15d | Pending | Nov 23, 2022 |
| 17927639 | AGENTS AND METHODS FOR TREATING TAUOPATHIES | The Regents of the University of California | HERNANDEZ, JACKSON J | 1627 | §112 | Final Rejection | — | Pending | Nov 23, 2022 |
| 17927112 | NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES | The Broad Institute, Inc. | LAFAVE, ELIZABETH ROSE | 1684 | §103 | Non-Final OA | — | Pending | Nov 22, 2022 |
| 17987511 | DYNAMIC ASSET TRACKING VIA LOW-ENERGY RADIO FREQUENCY DEVICES | Cognosos, Inc. | BILODEAU, DAVID | 2648 | §103 | Non-Final OA | 124d overdue | Pending | Nov 15, 2022 |
| 17923456 | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | Annexon, Inc. | WANG, CHANG YU | 1675 | §101§103§112Other | Non-Final OA | 26d overdue | Pending | Nov 04, 2022 |
| 17923296 | COMPOSITIONS COMPRISING ENZYMES AND PROBIOTICS, AND METHODS FOR PREVENTING OR TREATING MACULAR DEGENERATION | Genofocus, Inc. | PAGUIO FRISING, MICHELLE F | 1651 | §103Other | Final Rejection | 34d | Pending | Nov 04, 2022 |
| 18048238 | DISCOVERY AND ENGINEERING OF INTEGRASES FOR HIGH-EFFICIENCY GENE INTEGRATION | Massachusetts Institute Of Technology | KONOPKA, CATHERINE ANNE | 1635 | §101§102§103§112DP | Non-Final OA | — | Pending | Oct 20, 2022 |
| 17995969 | iPSC INDUCTION | Roslin Technologies Limited | MCCORMICK, CATHERINE LYNN | 1638 | §102§103 | Final Rejection | 45d overdue | Pending | Oct 11, 2022 |
| 17938186 | TEST DEVICE | Spd Swiss Precision Diagnostics GmbH | CHIU, MAY LEUNG | 1758 | §102§103 | Non-Final OA | — | Pending | Oct 05, 2022 |
| 17917233 | MANUFACTURING OF SYNTHETIC EXOSOMES FOR CNS AND NON-CNS DELIVERY OF THERAPEUTICS | The Regents of the University of California | RONEY, CELESTE A | 1612 | §103 | Final Rejection | 24d overdue | Pending | Oct 05, 2022 |
| 17947312 | METHODS FOR OBTAINING COMPOUNDS FROM A PLANT OR FUNGUS MATERIAL, RESPECTIVE COMPOSITIONS, AND USES THEREOF | Real Isolates, LLC | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Non-Final OA | 1d overdue | Pending | Sep 19, 2022 |
| 17905875 | COMPOSITIONS AND METHODS FOR MODULATING THE INTERACTION BETWEEN SS18-SSX FUSION ONCOPROTEIN AND NUCLEOSOMES | The Trustees of Princeton University | CLARKE, TRENT R | 1651 | §103§112 | Final Rejection | 70d | Pending | Sep 08, 2022 |
| 17903586 | COMPOSITIONS AND METHODS FOR STABILIZING BIOMOLECULES | Massachusetts Institute Of Technology | KIM, DANIELLE A | 1613 | §103 | Non-Final OA | 40d | Pending | Sep 06, 2022 |
| 17903567 | MEMBRANES FOR THE TARGETED EXTRACTION OF PHOSPHATE | The Regents of the University of California | RIPA, BRYAN D | 1794 | §103 | Final Rejection | — | Pending | Sep 06, 2022 |
| 17802824 | FUNCTIONAL HUMAN CORNEAL ENDOTHELIAL CELLS AND APPLICATION THEREOF | Kyoto Prefectural Public University Corporation | TINSLEY, BRENDAN THOMAS | 1634 | §112 | Final Rejection | — | Pending | Aug 26, 2022 |
| 17801055 | DESIGNER PEPTIDES AND PROTEINS FOR THE DETECTION, PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE, 2019 (COVID-19) | United Biomedical, Inc. | KINSEY WHITE, NICOLE ERIN | 1672 | §112 | Non-Final OA | 34d | Pending | Aug 19, 2022 |
| 17797610 | REAL-TIME DNN EXECUTION FRAMEWORK ON MOBILE DEVICES WITH BLOCK-BASED COLUMN-ROW PRUNING | College Of William & Mary | WERNER, MARSHALL L | 2125 | §101 | Non-Final OA | — | Pending | Aug 04, 2022 |
| 17877195 | COMBINATION THERAPY WITH NEOANTIGEN VACCINE | DANA-FARBER CANCER INSTITUTE, INC. | GODDARD, LAURA B | 1642 | §103§112 | Final Rejection | 19d overdue | Pending | Jul 29, 2022 |
| 17815844 | SYSTEMS FOR MEASURING PATIENT PHYSIOLOGIC PARAMETERS | UCHU Biosensors, Inc. | DOUGHERTY, SEAN PATRICK | 3791 | §112 | Non-Final OA | — | Pending | Jul 28, 2022 |
| 17794720 | PEPTIDE IMMUNOGENS TARGETING PITUITARY ADENYLATE CYCLASE-ACTIVATING PEPTIDE (PACAP) AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF MIGRAINE | United Biomedical, Inc. | LOCKARD, JON MCCLELLAND | 1647 | §112 | Non-Final OA | — | Pending | Jul 22, 2022 |
| 17866034 | PSMA LIGANDS FOR IMAGING AND ENDORADIOTHERAPY | Technische Universitat Munchen | PERREIRA, MELISSA JEAN | 1618 | §102§112DP | Non-Final OA | — | Pending | Jul 15, 2022 |
| 17789019 | TARGETING THE INTRINSIC APOPTOTIC MACHINERY IN GLIOBLASTOMA | The Regents of the University of California | VALLE, ERNESTO | 1623 | §103 | Final Rejection | — | Pending | Jun 24, 2022 |
| 17787007 | ALUMINOSILICATE GLASS | Macquarie University | FORSYTH, PAUL ALAN | 1731 | §102§103 | Non-Final OA | — | Pending | Jun 24, 2022 |
| 17786764 | INHIBITORS OF LIN28 AND METHODS OF USE THEREOF | The Regents of the University of California | BAUER, NICOLA MARIA | 1621 | §102 | Non-Final OA | 25d overdue | Pending | Jun 17, 2022 |
| 17829346 | RECIPROCATING MIXING AND INJECTOR SYSTEM | Windgap Medical, Inc. | SCHMIDT, EMILY LOUISE | 3783 | §103§112 | Non-Final OA | — | Pending | May 31, 2022 |
| 17780819 | METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA | Evelo Biosciences, Inc. | EIX, EMILY FAY | 1653 | §103 | Final Rejection | 52d overdue | Pending | May 27, 2022 |
| 17779002 | METHODS OF TREATING CANCER USING DKK-1 INHIBITORS | Leap Therapeutics, Inc. | SULLIVAN, DENNIS JOHN | 1642 | §103§112Other | Non-Final OA | 37d overdue | Pending | May 23, 2022 |
| 17770463 | PATIENT-MATCHED ORGANOID SYSTEMS FOR STUDYING CANCER | Massachusetts Institute Of Technology | THUESON, HANNA MARIE | 1638 | §103 | Non-Final OA | — | Pending | Apr 20, 2022 |
| 17723828 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISORDERS | Gnt Pharma Co., Ltd. | TRAN, ERIC | 1629 | §103§112 | Final Rejection | 89d overdue | Pending | Apr 19, 2022 |
| 17768778 | NON-CODING RNA PROTECTING AGAINST HEART FAILURE | Medizinische Hochschule Hannover | MARVICH, MARIA | 1634 | §112 | Final Rejection | 24d overdue | Pending | Apr 13, 2022 |
| 17718927 | CO-CULTURE METHOD FOR BIOFUEL AND BIOCHEMICAL PRODUCTION FROM UNTREATED SYNGAS | Northeastern University | BREEN, KIMBERLY CATHERINE | 1657 | §103§112 | Final Rejection | 66d overdue | Pending | Apr 12, 2022 |
| 17764043 | ENHANCING CANCER THERAPY TREATMENT WITH BH3 MIMETICS | The Regents of the University of Colorado | LU, CHENG | 1642 | §103§112 | Non-Final OA | 4d overdue | Pending | Mar 25, 2022 |
| 17696385 | TREATMENT OF H-RAS-DRIVEN TUMORS | Memorial Sloan-Kettering Cancer Center | CHONG, YONG SOO | 1623 | §103 | Final Rejection | — | Pending | Mar 16, 2022 |
| 17632449 | METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA | Evelo Biosciences, Inc. | PARAS JR, PETER | 1645 | §103 | Final Rejection | 43d overdue | Pending | Feb 02, 2022 |
| 17631169 | COMPOSITE MATERIALS | Anaphite Limited | MCKINNON, LASHAWNDA T | 1789 | §102§103 | Non-Final OA | 34d | Pending | Jan 28, 2022 |
| 17554823 | FAP-ACTIVATED RADIOTHERANOSTICS AND USES RELATED THERETO | Trustees Of Tufts College | WESTERBERG, NISSA M | 1618 | §103§112 | Final Rejection | 183d overdue | Pending | Dec 17, 2021 |
| 17553299 | LIPOSOMAL PREPARATIONS FOR NON-INVASIVE-PRENATAL OR CANCER SCREENING | Seracare Life Sciences, Inc. | JOHANNSEN, DIANA B | 1682 | §103 | Final Rejection | 19d | Pending | Dec 16, 2021 |
| 16964965 | ANTIBODY-DRUG CONJUGATES THAT TARGET DLK1 AND USES THEREOF | Y-Biologics, Inc. | PUTTLITZ, KARL J | 1646 | §103§112Other | Non-Final OA | 219d overdue | Pending | Nov 30, 2021 |
| 17598761 | MIXTURES OF SYNTHETIC COPOLYPEPTIDE HYDROGELS | The Regents of the University of California | BEANE, RANDALL L | 1654 | §103§112 | Non-Final OA | 16d overdue | Pending | Sep 27, 2021 |
| 17482579 | TREATMENT OF ALZHEIMER'S DISEASE (AD) WITH AN ALUMINUM SALT | Advantage Therapeutics, Inc. | TIEN, LUCY MINYU | 1612 | §103Other | Non-Final OA | 21d | Pending | Sep 23, 2021 |
| 17473362 | METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES USING FNDC5 | DANA-FARBER CANCER INSTITUTE, INC. | MARTINEZ, TARA L | 1654 | §101§112 | Non-Final OA | 99d overdue | Pending | Sep 13, 2021 |
| 17437643 | COMPOSITIONS, METHODS FOR REGULATING UTERINE, PLACENTAL GROWTH | The Regents of the University of California | SIMMONS, CHRIS E | 1622 | §103§112 | Non-Final OA | 22d | Pending | Sep 09, 2021 |
| 17464315 | METHODS FOR GENERATING INDUCED PLURIPOTENT STEM CELLS VIA CELL CYCLE SYNCHRONIZATION | Sapphiros Al Bio LLC | ABUZEINEH, HANAN ISAM | 1633 | §103 | Final Rejection | 111d overdue | Pending | Sep 01, 2021 |
| 17419030 | COMPOUNDS COMPRISING CLEAVABLE LINKER AND USES THEREOF | Intocell, Inc. | RHOADES, DEREK JAMES | 1692 | §112Other | Non-Final OA | — | Pending | Jun 28, 2021 |
| 17352493 | INTEGRATED IMAGING AND MEDICAL DEVICE DELIVERY APPARATUS AND METHOD OF USE | VASCUTEK LIMITED | PEHLKE, CAROLYN A | 3799 | §102§103 | Final Rejection | 18d overdue | Pending | Jun 21, 2021 |
| 17311180 | HETEROCYCLYL POLYMETHINE IR CHROMOPHORES | The Regents of the University of California | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Final Rejection | — | Pending | Jun 04, 2021 |
| 17296829 | T Cell-Directed Anti-Cancer Vaccines Against Commensal Viruses | The General Hospital Corporation | SIFFORD, JEFFREY MARK | 1671 | §103§112Other | Non-Final OA | 61d | Pending | May 25, 2021 |
| 17284363 | COMBINATION OF AN UROLITHIN WITH AN IMMUNOTHERAPY TREATMENT | Amazentis SA | MOU, LIYUAN | 1628 | §103§112DPOther | Non-Final OA | — | Pending | Apr 09, 2021 |
| 17265934 | MODULATING PTPN2 TO INCREASE IMMUNE RESPONSES AND PERTURBING GENE EXPRESSION IN HEMATOPOIETIC STEM CELL LINEAGES | President and Fellows of Harvard College | CUNNINGCHEN, KATHLEEN MARY | 1646 | §101§103§112 | Non-Final OA | 12d | Pending | Feb 04, 2021 |
| 15734445 | TUMOR MICROENVIRONMENT-ACTIVATED DRUG-BINDER CONJUGATES, AND USES RELATED THERETO | Avacta Life Sciences, Limited | VAN DRUFF, SYDNEY | 1643 | §103 | Final Rejection | 28d overdue | Pending | Dec 02, 2020 |
| 17053422 | STEM CELL-DERIVED CELL CULTURES, STEM CELL-DERIVED THREE DIMENSIONAL TISSUE PRODUCTS, AND METHODS OF MAKING AND USING THE SAME | The Regents of the University of Colorado | CORDAS, EMILY ANN | 1632 | §103§112 | Non-Final OA | 22d overdue | Pending | Nov 06, 2020 |
| 17089448 | Diagnostic Method | Amazentis SA | FRITCHMAN, REBECCA M | 1758 | §103§112 | Non-Final OA | 49d overdue | Pending | Nov 04, 2020 |
| 16980679 | METHODS FOR TREATING OCULAR DISEASES | Novartis AG | FONTAINHAS, AURORA M | 1675 | §103Other | Non-Final OA | — | Pending | Sep 14, 2020 |
| 16978362 | IPSC-DERIVED CELL COMPOSITIONS, AND RELATED SYSTEMS AND METHODS FOR CARTILAGE REPAIR | Orig3N, Inc. | MOSS, NATALIE M | 1653 | §101§103§112 | Non-Final OA | 53d overdue | Pending | Sep 04, 2020 |
| 16779005 | EXPANDABLE LUMINAL STENTS AND METHODS OF USE | Bolton Medical, Inc. | WOZNICKI, JACQUELINE | 3774 | §103§112 | Final Rejection | — | Pending | Jan 31, 2020 |
| 16741594 | ENCODING TEXTUAL DATA FOR PERSONALIZED INVENTORY MANAGEMENT | Punchh Inc. | RAMPHAL, LATASHA DEVI | 3688 | §101§103§112 | Final Rejection | 58d overdue | Pending | Jan 13, 2020 |
| 16623205 | PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND FORMULATIONS THEREOF FOR TREATMENT OF SYNUCLEINOPATHIES | UNS IP HOLDINGS, LLC | BUCKMASTER, MARLENE VRENI | 1672 | §102§103 | Non-Final OA | — | Pending | Dec 16, 2019 |
| 16433298 | TREATMENT OF MIGRAINE | Allergan Pharmaceuticals International Limited | CHONG, YONG SOO | 1623 | §103§112 | Final Rejection | 71d overdue | Pending | Jun 06, 2019 |
| 16423344 | Portable Drug Mixing and Delivery Device and Associated Methods | Windgap Medical, Inc. | SCHMIDT, EMILY LOUISE | 3783 | §103 | Non-Final OA | — | Pending | May 28, 2019 |
| 16333855 | SCN9A ANTISENSE OLIGONUCLEOTIDES | Olipass Corporation | SHIN, DANA H | 1635 | §112DP | Non-Final OA | — | Pending | Mar 15, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial